从出生开始重新连接瘤中性粒细胞
1School of Medicine, Westlake University, Hangzhou, Zhejiang, China.
Cancer cell
|June 6, 2025
概括
瘤进展改变了中性粒细胞的发育. 阻断介质素-1β (IL-1β) 恢复正常的颗粒形成,逆转免疫抑制,减少癌症转移,提供了一种新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 瘤的进展会引发影响免疫细胞发育的全身性变化,特别是颗粒形成.
- 来自瘤的信号与重编程髓状细胞分化有关.
- 中性粒细胞在癌症中起着复杂的作用,表现出支持和抗瘤的功能.
研究的目的:
- 为了研究瘤进展如何影响颗粒构造.
- 确定参与中性粒细胞发育重编程的特定信号.
- 评估针对这些信号的治疗潜力.
主要方法:
- 在瘤载体模型中分析骨髓状细胞的发育.
- 鉴定影响骨髓形成的瘤衍生因素.
- 使用IL-1β阻断的干预研究.
- 评估中性粒细胞功能和瘤转移.
主要成果:
- 来自瘤的信号重编程中性粒细胞的早期发育.
- 发现介素-1β (IL-1β) 阻断可以恢复正常的粒细胞形成.
- 阻断IL-1β逆转了中性粒细胞的免疫抑制印记.
- 向IL-1β显著减少了癌症转移.
结论:
- 瘤诱导的颗粒形成重编程是癌症进展的关键因素.
- IL-1β是这种重编程的关键媒介.
- 阻断IL-1β提供了一种有希望的策略,通过向中性粒细胞可塑性来恢复抗瘤免疫力并减少转移.
更多相关视频
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.1K
14:04Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
15.5K
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
